Help appealing denials for this first-in-class antibiotic for UTIs.

Appeal Your Blujepa Denial

Get access to this new oral antibiotic for uncomplicated UTIs.

Understanding Your Blujepa (gepotidacin) Denial

Blujepa (gepotidacin) is the first new class of oral antibiotic approved for uncomplicated urinary tract infections in nearly 30 years. It works against bacteria that have become resistant to older antibiotics. If you have recurrent UTIs or antibiotic allergies, this new option may be important for your care.

Common Reasons for Denial

! Prior authorization required
! Must try first-line antibiotics first
! Not medically necessary
! Culture and sensitivity not provided
! Resistance pattern not documented
! New drug with limited coverage policies

How We Help

We help you document your UTI history, antibiotic allergies or intolerances, culture results showing resistance, and why Blujepa is the appropriate antibiotic choice.

Start your Blujepa appeal — it takes about 3 minutes.

Some Types of Evidence We Can Use For Supporting Your Appeal

✓ Gepotidacin is a first-in-class triazaacenaphthylene antibiotic with a novel mechanism of action against common UTI pathogens.

✓ Clinical trials demonstrated effectiveness against E. coli and other common UTI-causing bacteria.

✓ New antibiotic classes are critically needed given increasing antibiotic resistance.

✓ Gepotidacin retains activity against bacteria resistant to fluoroquinolones and other commonly used antibiotics.

Patient Assistance & Copay Programs

These programs may help reduce your costs while you appeal:

GSK Patient Assistance

GSK offers copay assistance and patient assistance programs. Visit gskforyou.com or call 1-866-GSK-FOR-U (1-866-475-3678) for details on Blujepa coverage.

Eligibility requirements and program terms may change. Please verify current details directly with each organization.

Frequently Asked Questions

Blujepa may be appropriate when you have allergies to first-line antibiotics (like sulfa drugs or fluoroquinolones), your infection is caused by resistant bacteria, or you have recurrent UTIs that haven't responded to standard treatments.

Include urine culture results showing the bacteria causing your UTI, sensitivity testing showing resistance to other antibiotics, documentation of antibiotic allergies, and history of prior UTIs and treatments.

Ready to Fight Your Blujepa (gepotidacin) Denial?

Our free AI-powered tool will help you generate a compelling appeal letter in minutes.

Start Your Appeal Chat with AI Assistant

Disclaimer: Fight Health Insurance is not affiliated with, endorsed by, or partnered with any pharmaceutical manufacturer, healthcare provider, medical device company, or patient assistance program, including GlaxoSmithKline (GSK). All information provided is for educational and informational purposes only and does not constitute medical or legal advice. Please consult with your healthcare provider regarding treatment options and with your insurance company regarding coverage decisions.